Researchers keep returning to the same style of eating that has quietly shaped some of the healthiest places on earth.

A pooled analysis of four randomized trials found the dual neurokinin receptor antagonist elinzanetant showed no liver toxicity or cancer signals over 52 weeks, with mostly mild early side effects.

TOKYO, JP / ACCESS Newswire / October 15, 2026 / today released an analysis of 62,770,269 paid ad clicks classified as bot traffic by Spider AF from January through August 2026. Of those clicks, ...

A 2026 review pooled 22 trials and 1,723 patients. The headline is a lesson in how to read evidence, not a reason to stock up.

After Kittle, Hukporti, and a wave of high-profile tears, a 630-million-person study weighs in on Achilles injuries.

A pooled analysis of four phase III trials found longer OS in Asian patients with ES-SCLC receiving atezolizumab plus ...

Researchers identified 104 pregnancy and birth cohorts representing more than 1.17 million children across 41 countries, ...

The largest ever study of pooled sputum testing shows that combining up to four samples in a single Xpert MTB/RIF Ultra ...

Five presentations connect targeted intestinal exposure and sustained systemic drug exposure with PDE4 target engagement and early clinical ...

INmune Bio Inc. (Nasdaq: INMB) and Quantum Computing Inc. (Nasdaq: QUBT) today announced a collaboration to apply quantum ...

WASHINGTON, Oct. 10, 2026 / MemoDyne today published a reviews, side effects and ingredients guide that lists every ingredient on its capsule label and pairs each one with what the National Institutes ...

Older ambulatory patients with DMD who received delandistrogene moxeparvovec in clinical trials maintained more motor ...